BR0111378A - Kits e métodos para otimizar a eficácia de composições, condriprotetoras - Google Patents

Kits e métodos para otimizar a eficácia de composições, condriprotetoras

Info

Publication number
BR0111378A
BR0111378A BR0111378-0A BR0111378A BR0111378A BR 0111378 A BR0111378 A BR 0111378A BR 0111378 A BR0111378 A BR 0111378A BR 0111378 A BR0111378 A BR 0111378A
Authority
BR
Brazil
Prior art keywords
kits
composition
methods
approximately
present
Prior art date
Application number
BR0111378-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert Joseph Sarama
Judith Lynn Harris
Kris Eugene Spence
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0111378A publication Critical patent/BR0111378A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)
BR0111378-0A 2000-06-02 2001-06-01 Kits e métodos para otimizar a eficácia de composições, condriprotetoras BR0111378A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
PCT/US2001/017721 WO2001093833A2 (fr) 2000-06-02 2001-06-01 Necessaires et methodes pour optimiser l'efficacite de compositions de protection des cartilages

Publications (1)

Publication Number Publication Date
BR0111378A true BR0111378A (pt) 2003-06-17

Family

ID=24346049

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111378-0A BR0111378A (pt) 2000-06-02 2001-06-01 Kits e métodos para otimizar a eficácia de composições, condriprotetoras

Country Status (8)

Country Link
EP (1) EP1289531A2 (fr)
JP (1) JP2003535121A (fr)
CN (1) CN1431908A (fr)
AU (1) AU2001266648A1 (fr)
BR (1) BR0111378A (fr)
CA (1) CA2408611A1 (fr)
MX (1) MXPA02011940A (fr)
WO (1) WO2001093833A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003339318A (ja) * 2002-05-28 2003-12-02 Sanei Gen Ffi Inc 長期保存に安定な茶類飲料とその製造方法
JP4143387B2 (ja) * 2002-11-21 2008-09-03 株式会社アセロラフーズ 健康食品
AU2003903037A0 (en) * 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
CA2592842A1 (fr) * 2004-12-30 2006-07-13 Hill's Pet Nutrition, Inc. Procedes pour renforcer la palatabilite de compositions destinees a etre consommees par des animaux
US20090220649A1 (en) * 2005-03-14 2009-09-03 Sapporo Holding Limited Nutritionally Balanced Food or Beverage Product
EP1887854B1 (fr) * 2005-06-01 2017-10-04 Hill's Pet Nutrition, Inc. Procédés d'amélioration de la sapidité de compositions destinées à la consommation animale
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
CN116196319B (zh) * 2021-11-30 2024-06-04 内蒙古伊利实业集团股份有限公司 低聚糖在保护软骨中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
US4766209A (en) * 1986-03-10 1988-08-23 Nestec S. A. Amino sugar carbonating agents and their preparation
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
EP0991413A1 (fr) * 1997-04-10 2000-04-12 Richardson Labs, Inc. Composition renfermant une proteine de collagene hydrolysee et de la glucosamine, pour le traitement des arthroses
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
JP2000166467A (ja) * 1998-12-10 2000-06-20 Nippon Kefia Kk 乳発酵産物及びハーブ類を含有してなる健康食品
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
JP4173606B2 (ja) * 1999-06-18 2008-10-29 サントリー株式会社 低酸性飲料の製造方法
JP4249853B2 (ja) * 1999-08-09 2009-04-08 焼津水産化学工業株式会社 経口用皮膚潤い改善剤

Also Published As

Publication number Publication date
WO2001093833A3 (fr) 2002-04-25
JP2003535121A (ja) 2003-11-25
AU2001266648A1 (en) 2001-12-17
MXPA02011940A (es) 2003-04-22
CN1431908A (zh) 2003-07-23
WO2001093833A2 (fr) 2001-12-13
CA2408611A1 (fr) 2001-12-13
EP1289531A2 (fr) 2003-03-12

Similar Documents

Publication Publication Date Title
BR9911861A (pt) Inibidores de farnesil proteìna transferase com as propriedades radiossensibilizadoras in vivo
BRPI0415373A (pt) ácidos carboxìlicos macrocìclicos e acilsulfonamidas como inibidores de replicação de hcv
BRPI0408466A (pt) composições farmacêuticas de inibidores de cetp e uso dos referidos inibidores
BR112018015238A2 (pt) conjugado de anticorpo, anticorpo, kit, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou condição e para diagnosticar uma doença ou condição
BR0209689A (pt) Uso de fragmento de hmg como agente anti-inflamatório
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR0111381A (pt) Composições, kits e métodos para promover benefìcios definidos a saúde
BRPI0512213A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
BR9910296A (pt) Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
HUP0002322A2 (hu) Multivalens vakcinakészítmény kevert hordozóval
BRPI0416700A (pt) métodos para tratar obesidade, para alcançar perda de peso desejável, para evitar ganho de peso indesejável, e para facilitar a perda de peso em um indivìduo não sofrendo de depressão, métodos de manutenção de um peso estável e de redução do peso corporal em um indivìduo, composição farmacêutica, e, kit
BR9814018A (pt) Derivados de tienopirimidina e tienopiridina úteis como agentes anticâncer
BRPI0512220A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BRPI0411098A (pt) benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos
BR0107749A (pt) Métodos de uso de uma composição de bebida
DK1392329T3 (da) Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom
DK1056475T3 (da) Dendrimere fullerenderivater, fremgangsmåde til fremstilling heraf samt deres anvendelse som neuroprotektiva
BR0309993A (pt) Método para reduzir a produção de metano que emana das atividades digestivas de um animal, composição para alimentação, pré-mistura de alimentação, e, suplemento para água de beber
BR0109294A (pt) •ster polissacarìdico, composições farmacêuticas, uso do éster polissacarìdico, e, processo para a preparação dos ésteres polissacarìdicos
BR0111378A (pt) Kits e métodos para otimizar a eficácia de composições, condriprotetoras
BRPI0411092A (pt) benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos
BRPI0407243A (pt) Método e composição que usam astaxantina
BRPI0413404A (pt) composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired